Genalyte
PrivateLast Round
Series C
Extension
Apr 21, 2023
Est. Valuation
$302.19M
Total Funding Raised
$74.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Genalyte is a healthcare technology company that develops and provides diagnostic platforms for rapid, real-time blood testing at the point of care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Sensors, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genalyte Comparables
Compare Genalyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Truvian | 85% | |
| Vital Bio | 81% | |
| Osler Diagnostics | 78% |
Genalyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Apr 21, 2023 | ||||
| VC Round | Jan 11, 2021 | ||||
| VC Round | Nov 21, 2016 | ||||
| Series C | Aug 18, 2015 | ||||
| Grant | Aug 20, 2013 | ||||
Grant | Dec 11, 2012 |
Genalyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series C, Series C Extension, VC Round, Series B |
| National Cancer Institute | Grant |
| Khosla Ventures | Series C Extension, VC Round, Series C |
| Provenio Capital | Series C Extension, VC Round |
| Boutique Venture Partners | Series C Extension |
| Invus Opportunities | Series C Extension |
| HBM Healthcare Investments | Series C Extension, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 55% MoM.
- Mar 24, 2026
Merlin platform for diagnostic testing is in development.
Genalyte Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genalyte's valuation, stock price, and market status.
Is Genalyte a public or private company?
Genalyte is a private company.
What is the current stock price of Genalyte?
Genalyte is a private company with no public stock price. No recent secondary market data is available.
How much is Genalyte worth (valuation)?
Valuation information for Genalyte is not publicly available.
Can I buy Genalyte stock?
Genalyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genalyte's last funding round?
Genalyte's most recent funding round was Series C Extension on April 21, 2023.
Who are the main investors in Genalyte?
Key investors in Genalyte include Redmile Group, Khosla Ventures, Boutique Venture Partners.
Will Genalyte IPO soon?
No public IPO plans have been announced for Genalyte.
How can I track Genalyte secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genalyte's secondary market activity and sign up for updates.